Journal of Affective Disorders
Volume 77, Issue 1 , Pages 87-92 , October 2003

Does estrogen enhance the antidepressant effects of fluoxetine?

Received 28 September 2000 ,Accepted 1 May 2002.

References 

  1. Ahokas A, Kaukoranta J, Wahlbeck K, et al.  Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17β-estradiol: a preliminary study. J. Clin. Psychiatry. 2001;62:332–336
  2. Beck AT, Ward CH, Mendelson M. An inventory for measuring depression. Arch. Gen. Psychiatry. 1961;4:561–571
  3. Fink G, Sumner BE, Rosie R, Grace O, Quinn JP. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell. Mol. Neurobiol. 1996;16(3):325–344
  4. First MB, Spitzer RL, Gibbon M, Williams JB. In: Structured Clinical Interview for DSM-IV Axis I Disorder-Patient Edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute; 1995;
  5. Gregoire AJP, Kumar R, Everitt B, et al.  Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 1996;347:930–933
  6. Halbreich U, Rojansky N, Palter S, Tworek H, Hissin P, Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol. Psychiatry. 1995;37:434–441
  7. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  8. Kendall DA, Stancil AM, Enna SJ. Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science. 1981;211:1183–1185
  9. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Estrogen therapy for severe persistent depressions in women. Arch. Gen. Psychiatry. 1979;36:550–554
  10. Kronenberg F, Downey JA. Thermoregulatory physiology of menopausal hot flashes: a review. Can. J. Physiol. Pharmacol. 1987;65(6):1312–1324
  11. Prange AJ, Wilson IC, Alltop LB. Estrogen may well affect response to antidepressant. J. Am. Med. Assoc. 1972;219(2):143–144
  12. Purdie DW, Crichton CEJA, MacDonald L. Hormone replacement therapy, sleep quality and psychological well-being. Br. J. Obstet. Gynecol. 1995;102:735–739
  13. Schmidt PJ, Roca CA, Bloch M, Rubinow DR. The perimenopause and affective disorders. Semin. Reprod. Endocrinol. 1997;15(1):91–100
  14. Schmidt PJ, Nieman L, Danaceau MA, et al.  Estrogen replacement in perimenopause-related depression: a preliminary study. Am. J. Obstet. Gynecol. 2000;183:414–420
  15. Schneider LS, Finch CE. Can estrogens prevent neurodegeneration?. Drugs Aging. 1997;11(2):87–95
  16. Schneider LS, Small GW, Hamilton SH, Bystritsky A, Nemeroff CB, Meyers BS. Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. Am. J. Geriatr. Psychiatry. 1997;5(2):97–106
  17. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J. Clin. Endocrinol. Metab. 1991;72(2):336–343
  18. Sherwin BB, Cadotte BE. Up-regulatory effect of estrogen on platelet 3H-imipramine binding sites in surgically menopausal women. Biol. Psychiatr. 1990;28:339–348
  19. Soares CN, Almeida OP, Joffe H, et al.  Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind randomized, placebo-controlled trial. Arch. Gen. Psychiatry. 2001;58:529–534
  20. Stewart DE, Boydell KM. Psychologic distress during menopause: associations across the reproductive life cycle. Int. J. Psychiatry Med. 1993;23(2):157–162
  21. Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch. Gen. Psychiatry. 1977;34:98–111

PII: S0165-0327(02)00357-9

doi: 10.1016/S0165-0327(02)00357-9

Journal of Affective Disorders
Volume 77, Issue 1 , Pages 87-92 , October 2003

Article Tools

* Image Usage & Resolution